Your browser doesn't support javascript.
loading
Pre-existing conditions associated with post-acute sequelae of COVID-19.
Jacobs, Elizabeth T; Catalfamo, Collin J; Colombo, Paulina M; Khan, Sana M; Austhof, Erika; Cordova-Marks, Felina; Ernst, Kacey C; Farland, Leslie V; Pogreba-Brown, Kristen.
Afiliação
  • Jacobs ET; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA. Electronic address: jacobse@email.arizona.edu.
  • Catalfamo CJ; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Colombo PM; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Khan SM; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Austhof E; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Cordova-Marks F; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Ernst KC; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Farland LV; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
  • Pogreba-Brown K; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
J Autoimmun ; 135: 102991, 2023 02.
Article em En | MEDLINE | ID: mdl-36634460
ABSTRACT
Post-acute sequelae of COVID-19 (PASC) are conditions that occur or remain at least 28 days after SARS-CoV-2 infection. While some risk factors for PASC have been identified, little is known about pre-existing conditions that render one susceptible to developing PASC. Data from participants (n = 1224) in a longitudinal COVID-19 cohort study in Arizona were used to investigate comorbid conditions associated with PASC. After adjustment of the models for age, BMI, gender, race, and smoking, the following pre-existing conditions were statistically significantly associated with the development of PASC asthma (OR = 1.54; 95% CI = 1.10-2.15); chronic constipation (OR = 4.29; 95% CI = 1.15-16.00); reflux (OR = 1.54; 95% CI = 1.01-2.34); rheumatoid arthritis (OR = 3.69; 95%CI = 1.15-11.82); seasonal allergies (OR = 1.56; 95% CI = 1.22-1.98); and depression/anxiety (OR = 1.72; 95% CI = 1.17-2.52). When grouping conditions together, statistically significant associations with PASC were observed for respiratory (OR = 1.47; 95% CI = 1.06-2.14); gastrointestinal (OR = 1.62; 95% CI = 1.16-2.26), and autoimmune conditions (OR = 4.38; 95% CI = 1.59-12.06). After adjustment for severity of acute SARS-CoV-2 infection and depression/anxiety, seasonal allergies (OR = 1.48; 95% CI 1.15-1.91) and autoimmune disease (OR = 3.78; 95% CI - 1.31-10.91) remained significantly associated with risk for PASC. These findings indicate that numerous pre-existing conditions may be associated with an increased risk for the development of PASC. Patients with these conditions should consider taking extra steps to avoid infection.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doenças Autoimunes / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doenças Autoimunes / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article